Short: The Real Reason You're Not Losing Weight On A GLP-1

Most people who plateau on a GLP-1 medication think the drug stopped working. The drug didn't stop working. Something else changed, and it started changing the moment the medication did exactly what it was supposed to do.

Here is the full chain, and then we will zoom into the part that matters most.

GLP-1 medications work by mimicking something called glucagon-like peptide-1, which is a hormone your gut releases after eating that signals your brain to reduce hunger and slow the rate at which your stomach empties. The result is that food feels less urgent, portions feel satisfying at smaller sizes, and for many people appetite nearly disappears. Calorie intake drops, sometimes dramatically, and the scale moves fast in the first few weeks.

That early drop feels like progress, and some of it is. But a meaningful portion of it is water weight leaving your body because when you eat less, your body burns through its stored carbohydrate supply, something called glycogen, and every gram of glycogen holds roughly three to four grams of water attached to it. Burn the glycogen, lose the water. That is why the scale can drop several pounds in the first two weeks without much actual fat loss occurring yet.

Then the rate slows, and people think the drug has stopped working.

What has actually happened is that the easy, fast-moving phase is over and a slower, more complicated process has taken over. Real fat loss is slower than water loss, so some of the deceleration is simply physics. But for a lot of people, something more damaging is also happening underneath the surface.

When your appetite disappears and your total food intake drops significantly, your protein intake almost always drops with it. Not because you made a bad choice, but because protein is in food, and you are eating less food. It follows the same direction.

The problem is that your body runs a constant calculation about how much muscle to maintain. Muscle is metabolically expensive, meaning your body has to spend calories just to keep it alive and operational, and your body will not spend those calories on tissue it does not need. The signal that tells your body it needs muscle is use. Specifically, resistance, load, training. Without that signal, and without enough protein coming in to support the tissue, your body starts breaking muscle down to harvest the amino acids inside it for other functions that it considers higher priority.

This process is called lean mass catabolism, which is just the technical name for your body dismantling its own muscle for parts.

Think of your metabolism like a factory floor. The number of workers you have determines how much output the factory can produce. Muscle tissue is the workers. When your calorie deficit is large and protein is low, the factory starts laying off workers because it cannot justify the payroll. Fewer workers means less output, which means fewer calories burned at rest each day. The same deficit that was producing fat loss now produces less and less because the engine running the whole operation has gotten smaller.

That is the plateau. Not the drug failing. The body adapting to conditions you accidentally created.

The reason this matters beyond just the number on the scale is that muscle tissue is the primary site where your body burns glucose, and it is a large driver of your resting metabolic rate, which is the number of calories you burn just existing throughout the day. Lose enough of it and you are not just stalling weight loss, you are reshaping your metabolism in a direction that makes maintaining any future weight loss harder.

So the fix is two things, and they work together.

The first is treating protein intake like a non-negotiable number rather than something that happens by default. A practical target that appears consistently across the research is your goal body weight in pounds converted to grams of protein per day. If your target weight is 170 pounds, you are aiming for 170 grams of protein every day, regardless of how hungry you feel. This matters because the GLP-1 medication is suppressing your appetite signal, but it is not telling your body that protein requirements have changed. Your muscle tissue still needs the raw material to be maintained, and that material is dietary protein.

The second is resistance training two to three times per week. This is the signal. Muscle is not maintained because you want it to be. It is maintained because you are giving your body a mechanical reason to keep it. Lifting weights creates a demand for that tissue to exist, and when that demand is present alongside adequate protein, the body will preserve lean mass even in a significant calorie deficit.

A case series published in 2025 showed what this combination looks like in practice. Patients on semaglutide or tirzepatide who followed structured resistance training three to five times per week and hit their protein targets lost an average of 33 percent of their total body weight with only 6.9 percent of that loss coming from lean mass. One patient in the series gained 2.5 percent lean mass while losing 26.8 percent of their body weight total. These were people on the same medications that others plateau on, and the difference in outcome was not the drug. The drug was the same. The difference was what they did with the appetite suppression window the drug created.

That framing is worth sitting with. The GLP-1 medication does not cause fat loss directly. It reduces appetite, which creates the conditions for a calorie deficit, which creates the possibility of fat loss. What happens to body composition inside that deficit is determined by protein intake and training load. The drug creates a window. The window is only as valuable as what you build inside it.

Most people who plateau are not stuck because the drug lost its effect. They are stuck because their metabolism quietly shrank while they were focused on the scale, and the scale is a poor instrument for measuring what is actually happening to your body composition. The number stopped moving because the engine got smaller, and the engine got smaller because nothing was telling it to stay.

---

References

1. Tinsley GM, Nadolsky S. Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series. SAGE Open Medical Case Reports. 2025. Finding: Patients on semaglutide/tirzepatide who trained 3-5x/week and prioritized protein lost 33% body weight with only 6.9% muscle loss; one gained 2.5% muscle while losing 26.8% body weight. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness